Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model

Introduction: Generic pharmaceuticals account for the majority of the $359 billion US pharmaceutical market, including for cardiology drugs. Amidst a lack of price transparency and administrative inefficiencies, generic drug prices are high, causing an undue burden on patients. Methods: We identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Narendrula, Aparna, Lang, Jacob, Mossialos, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506155/
https://www.ncbi.nlm.nih.gov/pubmed/37727389
http://dx.doi.org/10.3389/fphar.2023.1179253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506155/
https://www.ncbi.nlm.nih.gov/pubmed/37727389
http://dx.doi.org/10.3389/fphar.2023.1179253

Ejemplares similares